ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03
Amendments to the Article of Incorporation or Bylaws;
Changes in Fiscal Year
On November 9, 2016, the shareholders of Zivo Bioscience, Inc.
approved Articles of Amendment (the Articles of Amendment)
amending the Companys Articles of Incorporation to increase the
number of the Companys authorized shares of common stock from
300,000,000 to 450,000,000. The Articles of Amendment were filed
with the Secretary of State of the State of Nevada on, and
effective as of, November 14, 2016. A copy of the Articles of
Amendment is attached as Exhibit 3.1 to this Current Report on
Form 8-K and is incorporated herein by reference.
Item 5.07
Submission of Matters to a Vote of Security
Holders
At the annual meeting of the shareholders of Zivo Bioscience,
Inc. on November 9, 2016, shareholders: (1) elected the five
nominees for Board of Directors to serve until the next annual
meeting of shareholders in 2017 and until his/her successor is
elected and qualified; and (2) approved the proposal to amend the
Companys Articles of Incorporation to increase the authorized
shares of common stock from 300,000,000 to 450,000,000. The
results of the voting are shown below.
Proposal 1 Election of Directors
|
Nominees |
Votes For |
Against |
Abstain |
Not Voted |
|
Christopher D. Maggiore |
34,582,964 |
3,000 |
978,295 |
64,657,901 |
|
Nola E. Masterson |
34,136,651 |
449,313 |
978,295 |
64,657,901 |
|
John B. Payne |
34,136,651 |
449,313 |
978,295 |
64,657,901 |
|
Robert O. Rondeau |
34,130,661 |
455,313 |
978,295 |
64,657,901 |
|
Philip M. Rice II |
34,127,651 |
458,313 |
978,295 |
64,657,901 |
Proposal 2 Increase in Authorization of Shares from
300,000,000 to 450,000,000
|
Votes For |
Against |
Abstain |
|
83,544,280 |
16,038,183 |
639,697 |
Item 9.01
Financial Statements and Exhibits
(d)
Exhibits.
3.1
Articles of Amendment, as filed with the Secretary of State of
the State of Nevada on November 14, 2016.
About ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO)
Zivo Bioscience, Inc., formerly Health Enhancement Products, Inc., is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients. It focuses to sell natural bioactive ingredients derived from its algae cultures to animal, human and dietary supplement and medical food manufacturers. It is also engaged in development of biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. It focuses on developing, manufacturing, marketing and selling tests that allow users to optimize personal health and identify future health risks. The Company manufactures algal products and derivatives, and has various product platforms. ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) Recent Trading Information
ZIVO BIOSCIENCE, INC. (OTCMKTS:ZIVO) closed its last trading session down -0.0060 at 0.0890 with 28,200 shares trading hands.